Vr Adviser, LLC Centessa Pharmaceuticals PLC Transaction History

Vr Adviser, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.18 - $9.85 $1.31 Million - $4.05 Million	-411,361 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$7.45 - $11.59 $5.33 Million - $8.3 Million	-715,911 Reduced 63.51%	411,361 $3.69 Million
Q2 2021 Aug 13, 2021	BUY	$21.71 - $25.66 $24.5 Million - $28.9 Million	1,127,272 New	1,127,272 $25 Million

108

118M

5.9K

53K

Ticker CNTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,339,296
Market Cap $1.65B
Description
Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

Stay updated on Vr Adviser, LLC with notifications on news.